TR200002790T2 - 5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip - Google Patents

5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip

Info

Publication number: TR200002790T2
Authority: TR; Turkey
Prior art keywords: thiazolidin; dione; pyridyl; ethoxy; benzyl
Prior art date: 1997-06-05

Application number

TR2000/02790T

Other languages

English (en)

Turkish (tr)

Inventor

Patel Jai

Ross Hamish

Price Robin

Roger Granett Jeffrey

Nigel Wray Paul

Original Assignee

Smithkline Beecham P.L.C.

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2001-11-21

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham P.L.C., Smithkline Beecham Corporation filed Critical Smithkline Beecham P.L.C.

2001-11-21 Publication of TR200002790T2 publication Critical patent/TR200002790T2/xx

Links

ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

TR2000/02790T 1997-06-05 1998-06-02 5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip TR200002790T2 (tr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition

Publications (1)

Publication Number	Publication Date
TR200002790T2 true TR200002790T2 (tr)	2001-11-21

Family

ID=26311662

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TR2000/02790T TR200002790T2 (tr)	1997-06-05	1998-06-02	5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip
TR1999/02963T TR199902963T2 (xx)	1997-06-05	1998-06-02	5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
TR1999/02963T TR199902963T2 (xx)	1997-06-05	1998-06-02	5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (fr)
JP (1)	JP2001521553A (fr)
KR (1)	KR20010013410A (fr)
CN (3)	CN1112926C (fr)
AP (1)	AP1214A (fr)
AR (2)	AR015120A1 (fr)
AU (1)	AU8215098A (fr)
BG (1)	BG104048A (fr)
BR (1)	BR9810405A (fr)
CA (2)	CA2333352A1 (fr)
CO (1)	CO4940400A1 (fr)
DZ (1)	DZ2510A1 (fr)
EA (1)	EA002384B1 (fr)
GB (1)	GB9711683D0 (fr)
HU (1)	HUP0004070A3 (fr)
ID (1)	ID24264A (fr)
IL (1)	IL133074A0 (fr)
MX (1)	MXPA99011322A (fr)
NO (2)	NO995938L (fr)
NZ (2)	NZ523725A (fr)
OA (1)	OA11306A (fr)
PE (1)	PE78899A1 (fr)
PL (1)	PL337201A1 (fr)
SK (1)	SK164899A3 (fr)
TR (2)	TR200002790T2 (fr)
TW (1)	TW570797B (fr)
UY (1)	UY25032A1 (fr)
WO (1)	WO1998055122A1 (fr)
ZA (2)	ZA984826B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
EP1903043A1 (fr)	1999-04-23	2008-03-26	SmithKline Beecham P.L.C.	Nouveau composé pharmaceutique
UA67844C2 (uk) *	1999-04-23	2004-07-15	Смітклайн Бічам Плс	Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
WO2003050112A1 (fr) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Hydrates de toluenesulfonate d'un derive de thiazolidinedione
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
EP2270007A1 (fr) *	2006-05-09	2011-01-05	Teva Pharmaceutical Industries Ltd.	Acide 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioique, procédés de préparation et compositions avec le maléate de rosiglitazone
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (fr) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Composés hétécycliques bicycliques utilisés en tant que modulateurs des ror-gamma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0842925A1 (fr) *	1987-09-04	1998-05-20	Beecham Group Plc	Thiazolidinédiones substituées
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
CA2182986A1 (fr) *	1994-02-10	1995-08-17	Smithkline Beecham P.L.C.	Utilisation de sensibilisateurs a l'insuline dans le traitement de l'insuffisance renale
EA199800177A1 (ru) *	1995-08-10	1998-10-29	Варнер-Ламберт Компани	Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
WO1997018811A1 (fr) *	1995-11-17	1997-05-29	Warner-Lambert Company	Procede de traitement de dystrophie myotonique
IL120443A (en) *	1996-03-18	2000-07-16	Sankyo Co	Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
CA2260044A1 (fr) *	1996-07-12	1998-01-22	Stephen Alistair Smith	Nouveau traitement contre la resistance a la leptine

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 EP EP98932144A patent/EP0998284A1/fr not_active Withdrawn
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/fr not_active Abandoned
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/fr not_active Ceased
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/fr not_active Ceased
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/fr not_active Expired - Fee Related
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/fr active
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1998055122A1 (fr)	1998-12-10
AU8215098A (en)	1998-12-21
IL133074A0 (en)	2001-03-19
CA2333352A1 (fr)	1998-12-10
CA2292629A1 (fr)	1998-12-10
AP9901696A0 (en)	1999-12-31
ID24264A (id)	2000-07-13
NO20040738L (no)	2000-02-02
NO995938L (no)	2000-02-02
TW570797B (en)	2004-01-11
NZ513922A (en)	2001-09-28
DZ2510A1 (fr)	2003-01-25
ZA9811572B (en)	1999-07-22
JP2001521553A (ja)	2001-11-06
AR008198A1 (es)	1999-12-29
EA199901116A1 (ru)	2000-06-26
UY25032A1 (es)	1998-11-26
NO995938D0 (no)	1999-12-03
CO4940400A1 (es)	2000-07-24
CN1526391A (zh)	2004-09-08
EP0998284A1 (fr)	2000-05-10
CN1430959A (zh)	2003-07-23
BG104048A (bg)	2000-07-31
PL337201A1 (en)	2000-08-14
CN1259050A (zh)	2000-07-05
CN1112926C (zh)	2003-07-02
ZA984826B (en)	1999-08-03
BR9810405A (pt)	2000-08-29
AP1214A (en)	2003-10-08
EA002384B1 (ru)	2002-04-25
PE78899A1 (es)	1999-10-22
CA2292629C (fr)	2004-01-06
AR015120A1 (es)	2001-04-18
TR199902963T2 (xx)	2000-02-21
SK164899A3 (en)	2000-11-07
HUP0004070A2 (hu)	2002-02-28
MXPA99011322A (es)	2004-12-02
NZ523725A (en)	2004-09-24
KR20010013410A (fr)	2001-02-26
HUP0004070A3 (en)	2002-03-28
OA11306A (en)	2003-10-22
GB9711683D0 (en)	1997-08-06

Publication	Publication Date	Title
EA200601145A1 (ru)	2009-04-28	Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов
TR200002790T2 (tr)	2001-11-21	5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip
HRP20020416B1 (hr)	2011-04-30	Novi pripravak i upotreba
NZ509239A (en)	2002-10-25	2-(4-(N-salicyloyl)aminophenyl)propionic acid useful as a carrier in compositions for delivering active agents
AP1545A (en)	2006-01-12	Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
TR200001793T2 (tr)	2000-10-23	Yapısında değişiklik yapılmış tiyazolidinediyon türevi, bunun hazırlanması için işlem ve eczacılık alanında kullanımı
SI1280797T1 (en)	2005-04-30	Inhibitors of dipeptidyl peptidase iv
DE59702414D1 (de)	2000-11-02	Dipeptidische benzamidine als kininogenasen-inhibitoren
JO2239B1 (en)	2004-10-07	Method for preparing benzothophen derivatives
MY135973A (en)	2008-07-31	Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative
NZ504704A (en)	2003-03-28	Hydrate of 5-[4-[2- (N-methyl-N- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt
AR015894A1 (es)	2001-05-30	Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos
HRP20000263B1 (en)	2009-01-31	Process for the preparation of thiazolidinedione derivatives
TR200103040T2 (tr)	2002-04-22	Yeni farmasötik maddeler
TR200103041T2 (tr)	2002-03-21	Yeni farmastik maddeler.
NZ515555A (en)	2002-09-27	Treatment of diabetes with thiazolidinedione and sulphonylurea
AP1715A (en)	2007-02-28	The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
UY25051A1 (es)	2000-09-29	Composiciones para el tratamiento de diabetes mellitus
CZ20011832A3 (cs)	2001-10-17	Nový farmaceutický přípravek a způsob jeho přípravy
ATE337313T1 (de)	2006-09-15	5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz
GB0021784D0 (en)	2000-10-18	Novel pharmaceutical
CY1107421T1 (el)	2012-12-19	Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης
HRP20010344B1 (en)	2008-02-29	Novel method of treatment
AP1738A (en)	2007-05-07	Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AP2002002684A0 (en)	2002-12-31	5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical